Company Filing History:
Years Active: 2018
Title: Vincent Vuaroqueaux: Innovator in Cancer Treatment Prediction
Introduction
Vincent Vuaroqueaux is a notable inventor based in Hesingue, France. He has made significant contributions to the field of cancer treatment, particularly in predicting the outcomes of anthracycline therapy for patients with cell proliferative disorders. His innovative work has the potential to enhance treatment efficacy and patient care.
Latest Patents
Vincent Vuaroqueaux holds a patent for "Markers for the prediction of outcome of anthracycline treatment." This invention relates to methods for predicting the effectiveness of anthracycline treatment by determining the expression levels of specific genes, including PITX2, TFF1, and PLAU. The patent also encompasses sequences, oligonucleotides, and antibodies that can be utilized in these predictive methods. He has 1 patent to his name.
Career Highlights
Vincent is currently associated with Therawis Diagnostics GmbH, where he continues to work on innovative solutions in diagnostics and treatment prediction. His expertise in molecular biology and genetics has positioned him as a key player in the development of predictive markers for cancer therapies.
Collaborations
Vincent has collaborated with esteemed colleagues, including John Foekens and John W Martens. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of cancer treatment.
Conclusion
Vincent Vuaroqueaux's contributions to cancer treatment prediction exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer therapy.